The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations
Open accessAbstract
Brucellosis is probably the commonest anthropozoonotic infection worldwide [1-3], but remains in various aspects an enigma in the 21st century [4]. Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis, while rare but persisting cases of B. canis human infection and disease by novel Brucella pathogens of marine mammals have also emerged. The disease is re-emerging as a significant cause of travel-related disease [5] and represents an index of poor socioeconomic status (Figure 1). Its treatment is largely based even today on the principles applied half a century ago by pioneer researchers [6] and few modifications have been made in the following years, despite the emergence of new antibiotic classes and different therapeutic approaches [7].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
The new global map of human brucellosis
Pappas, G., Papadimitriou, P., Akritidis, N., Christou, L., & Tsianos, E. V. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70382-6 · Cited by 2,264
Self-citationCorbel, M. J. (1997) · Emerging Infectious Diseases · doi:10.3201/eid0302.970219 · Cited by 1,295
Self-citationAn Overview of Human Brucellosis
Young, E. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.283 · Cited by 854
Self-citationRoushan, M. R. H., Mohraz, M., Hajiahmadi, M., Ramzani, A., & Valayati, A. A. (2006) · Clinical Infectious Diseases · doi:10.1086/501359 · Cited by 724
Self-citationTreatment of human brucellosis with doxycycline and gentamicin
Solera, J., Espinosa, A., Martínez-Alfaro, E., Sánchez, L., Geijo, P., Navarro, E., Escribano, J., & Fernández, J. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.80 · Cited by 685
Self-citationClinical Pharmacokinetics of Doxycycline and Minocycline
Saivin, S., & Houin, G. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815060-00001 · Cited by 350
Once-Daily Aminoglycoside Dosing in Immunocompetent Adults: A Meta-Analysis
Hatala, R., Dinh, T., & Cook, D. J. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00003 · Cited by 298
Brucellar Spondylitis: Review of 35 Cases and Literature Survey
Solera, J., Lozano, E., Martinez-Alfaro, E., Espinosa, A., Castillejos, M. L., & Abad, L. (1999) · Clinical Infectious Diseases · doi:10.1086/313524 · Cited by 294
Self-citationRecognition and Optimum Treatment of Brucellosis
Solera, J., Martinez-Alfaro, E., & Espinosa, A. (1997) · Drugs · doi:10.2165/00003495-199753020-00005 · Cited by 262
Self-citationHuman Brucellosis in Kuwait: A Prospective Study of 400 Cases
(1988) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068178 · Cited by 260
Khan, M. Y., Mah, M. W., & Memish, Z. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319758 · Cited by 208
Self-citationBrucella Endocarditis: Clinical, Diagnostic, and Therapeutic Approach
Reguera, J. M., Alarc�n, A., Miralles, F., Pach�n, J., Ju�rez, C., & Colmenero, J. D. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1026-z · Cited by 154
Self-citationMultivariate model for predicting relapse in human brucellosis
Solera, J., Martínez-Alfaro, E., Espinosa, A., Castillejos, M. L., Geijo, P., & Zapata, M. R. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)93342-4 · Cited by 115
Self-citationPossible implications of doxycycline-rifampin interaction for treatment of brucellosis
Colmenero, J. D., Fernández-Gallardo, L. C., Agúndez, J. A. G., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2798 · Cited by 93
Self-citationGenetic Bases of the Rifampin Resistance Phenotype in Brucella spp
Marianelli, C., Ciuchini, F., Tarantino, M., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5439-5443.2004 · Cited by 80
Tigecycline: A Novel Glycylcycline
Rubinstein, E., & Vaughan, D. (2005) · Drugs · doi:10.2165/00003495-200565100-00002 · Cited by 76
Self-citationMagoffin, R. L., & Ww, S. (1950) · PubMed · Cited by 72
Lecároz, C., Blanco‐Prieto, M. J., Burrell, M. A., & Gamazo, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl257 · Cited by 71
Treatment of Human Brucellosis with Rifampin plus Minocycline
Cascio, A., Scarlata, F., Giordano, S. H., Antinori, S., Colomba, C., & Titone, L. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.3.248 · Cited by 30
Self-citation
Cited by
Spondylodiscitis: update on diagnosis and management
Gouliouris, T., Aliyu, S. H., & Brown, N. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq303 · Cited by 780
Clinical Manifestations of Human Brucellosis: A Systematic Review and Meta-Analysis
Dean, A. S., Crump, L., Greter, H., Hattendorf, J., Schelling, E., & Zinsstag, J. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001929 · Cited by 537
Global Burden of Human Brucellosis: A Systematic Review of Disease Frequency
Dean, A. S., Crump, L., Greter, H., Schelling, E., & Zinsstag, J. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001865 · Cited by 534
Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials
Skalsky, K., Yahav, D., Bishara, J., Pitlik, S., Leibovici, L., & Paul, M. (2008) · BMJ · doi:10.1136/bmj.39497.500903.25 · Cited by 300
Chtarto, A., Humbert-Claude, M., Bockstael, O., Das, A. T., Boutry, S., Breger, L. S., Klaver, B., Melas, C., Barroso-Chinea, P., Gonzalez-Hernandez, T., et al. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.27 · Cited by 43
Metadata
- Authors
- Ariza, J., Bosilkovski, M., Cascio, A., Colmenero, J. D., Corbel, M. J., Falagas, M. E., Memish, Z. A., Roushan, M. R. H., Rubinstein, E., Sipsas, N. V., Solera, J., Young, E. J., & Pappas, G.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-12-27
- Volume
- 4
- Issue
- 12
- Pages
- e317
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2109844604
- Cited by
- 459
- References
- 20
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.